Paraoxonase1 gene polymorphisms as predictors of cardiovascular events in stable coronary artery disease / Polimorfismos no gene paraoxonase 1 como preditores de eventos cardiovasculares em pacientes com doença coronária estável
AUTOR(ES)
Letícia de Araujo Funari Ferri
DATA DE PUBLICAÇÃO
2010
RESUMO
Paraoxonase 1 (PON1) gene polymorphisms have a known relation with lipid metabolism, conferring a marginal and modest effect on serum lipoprotein concentrations and also on development of coronary artery disease (CAD). The primary objective of this study is to investigate the association between PON1 polymorphisms: R192Q- rs662, R160G: rs13306698, Leu55Met: rs854560, Promoter_161: rs705381, and rs3917464 and 5-year follow-up cardiovascular events in a subpopulation with stable CAD from MASS II (Medical, Angioplasty or Surgery Study II). Secondary objectives will be to evaluate the influence of these polymorphisms on baseline and 5-year follow-up lipid concentrations and also its association with combined cardiovascular events in the MASS II group randomized for medical treatment. MASS II had 611 patients randomized. Target population comprises 518 patients who had genetic material sampled. Even though the polymorphisms were linked to HDL-c metabolism, there was a low association with lipid levels and changes over the 5-year follow-up. HDL-c mean concentrations were different in the Promoter_161 genotypes, T-allele was associated with lower levels (p=0.0369). Univariate analysis showed association between the rare G-allele of polymorphism R160G (5 patients) and increased mortality, but when adjusted in the multivariate logistic regression model this variable was not independent predictor of mortality in this population. In the medical treatment group, r192Q is associated with new myocardium infarction (MI), combined events and death. When compared to AA genotype, GG genotype increased the risk of death by 7.69 (CI: 1.65- 35.76) and of MI by 6.58 (CI: 1.39- 30.46). A-allele is independently associated with combined cardiovascular events with a OR of 3.03 (CI: 1.29- 7.07). In conclusion, this study showed association between G-allele on R160G position with increased mortality in patients with stable CAD. R192Q polymorphism is associated with higher risk of death, MI and combined cardiovascular events in patients treated medically.
ASSUNTO(S)
marcadores genéticos cardiovascular disease coronary disease lipídeos doenças cardiovasculares genetic polymorphism genetic markers prognóstico polimorfismo genético prognosis doenças das coronárias lipids
Documentos Relacionados
- Parâmetros ecocardiográficos como preditores de eventos cardiovasculares em pacientes em hemodiálise
- Does intensified cholesterol lowering provide greater protection from cardiovascular events among patients with stable coronary artery disease?
- Preditores de eventos cardiácos maiores em pacientes com cardiopatia isquêmica estável
- Identification of genetic markers with diagnosis and prognosis potential in coronary artery disease
- Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study